Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125203981 | 12520398 | 1 | I | 201603 | 20160223 | 20160701 | 20160701 | EXP | CA-AMGEN-CANSP2016028207 | AMGEN | 50.00 | YR | A | F | Y | 0.00000 | 20160701 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125203981 | 12520398 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, UNK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | ||||||
| 125203981 | 12520398 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 20 MG, QWK | 0 | 20 | MG | /wk | |||||||
| 125203981 | 12520398 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | 500 ML, BID | 0 | 500 | ML | BID | |||||||
| 125203981 | 12520398 | 4 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 200 MG, BID | 0 | 200 | MG | BID | ||||||||
| 125203981 | 12520398 | 5 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125203981 | 12520398 | 1 | Rheumatoid arthritis |
| 125203981 | 12520398 | 2 | Rheumatoid arthritis |
| 125203981 | 12520398 | 3 | Rheumatoid arthritis |
| 125203981 | 12520398 | 5 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125203981 | 12520398 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125203981 | 12520398 | Arthralgia | |
| 125203981 | 12520398 | Bed rest | |
| 125203981 | 12520398 | C-reactive protein abnormal | |
| 125203981 | 12520398 | Dizziness | |
| 125203981 | 12520398 | Fall | |
| 125203981 | 12520398 | Gait disturbance | |
| 125203981 | 12520398 | Grip strength decreased | |
| 125203981 | 12520398 | Hepatotoxicity | |
| 125203981 | 12520398 | Hypersensitivity | |
| 125203981 | 12520398 | Hypokinesia | |
| 125203981 | 12520398 | Joint swelling | |
| 125203981 | 12520398 | Pain | |
| 125203981 | 12520398 | Pain in extremity | |
| 125203981 | 12520398 | Peripheral swelling | |
| 125203981 | 12520398 | Red blood cell sedimentation rate abnormal | |
| 125203981 | 12520398 | Rheumatoid factor positive | |
| 125203981 | 12520398 | Swelling | |
| 125203981 | 12520398 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125203981 | 12520398 | 1 | 2011 | 2016 | 0 | |
| 125203981 | 12520398 | 2 | 2004 | 2014 | 0 | |
| 125203981 | 12520398 | 3 | 201512 | 2016 | 0 | |
| 125203981 | 12520398 | 4 | 2004 | 0 | ||
| 125203981 | 12520398 | 5 | 20160315 | 0 |